Skip to main content

Closed

CTSO: Cytosorbents Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+4.1% / yr

Operating margin-36.0%

ROIC-41.2%

Financially safe

Stretched

Debt / equity8.64×

Interest coverage-11.6×

Current ratio1.09×

Cytosorbents Corporation

CTSONASDAQ Capital Market·USD·Closed

Cytosorbents Corporation

CTSONASDAQ·USD·Closed

$0.36

+3.08%

$0.36

+$0.01 (3.08%)

52W Range

1thpctl

Volume

0.55×avg

Mkt Cap

22.68MUSD

P/E

-1.9TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.55×avg

Market Cap

22.68MUSD

P/E Ratio

-1.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings